The relationship between climate change and infectious disease is raising questions around therapeutic innovation, logistical ...

This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024 ...

There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK 's Menveo vaccine ...

The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.

Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.

Outlook Therapeutics ’ second attempt to obtain US approval for its wet age-related macular degeneration (wet AMD) therapy, ...

Arrowhead has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics for rare genetic disease ...

In recent years, the evolution of biologic therapies for severe asthma has paralleled advancements in other chronic ...

With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...

The EC has approved BeiGene’s PD-1 inhibitor Tevimbra in combination with chemotherapy to treat ESCC and G/GEJ adenocarcinoma ...

In an advancement for diabetes management, the US Food and Drug Administration (FDA) has granted clearance to Medtronic’s new ...